# Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China

> **NCT04515082** · — · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 4800 (estimated)

## Conditions studied

- Colorectal Neoplasm
- Colorectal Cancer
- Adenomatous Polyps
- Adenoma
- Advanced Adenoma
- Serrated Polyp

## Interventions

- **DIAGNOSTIC_TEST:** Stool-based SDC2 and SFRP2 DNA methylation test
- **DIAGNOSTIC_TEST:** FIT

## Key facts

- **NCT ID:** NCT04515082
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 4800 (ESTIMATED)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04515082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04515082, "Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04515082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*